---
title: "GxP Validation in Clinical Software Development (Appsilon)"
aliases: ["GxP Validation in Clinical Software Development (Appsilon)"]
type: source
tags: [gxp, validation, fda, regulatory, sdlc, software-engineering, r]
created: 2026-04-29
updated: 2026-04-29
sources: 1
---

# GxP Validation in Clinical Software Development (Appsilon)

**Raw file**: `raw/sources/What is GxP Validation in Clinical Software Development.md`  
**Author(s)**: Paweł Przytuła (Appsilon)  
**Year**: 2024  
**Type**: blog-post  
**Venue**: Appsilon Blog (https://www.appsilon.com)

## Summary

A practical overview of GxP validation requirements for clinical software, aimed at biostatisticians and clinical developers preparing for FDA/EMA submissions. Covers the seven GxP "Good Practice" categories, six good software engineering practice domains, and the Software Development Life Cycle (SDLC) framework mandated by FDA. Emphasizes that validation is not just a QA checkbox but a foundation for data integrity, patient safety, and regulatory compliance.

## Key Points

- **GxP categories relevant to software**: CGMP (manufacturing), GLP (laboratory), GCP (clinical trials), GDP (distribution), GVP (pharmacovigilance), GAMP (automated manufacturing)
- **Seven good software practices**: development (version control, code review), reproducibility (dependency management, change control), validation (V&V, unit/integration/E2E testing, risk-based), cybersecurity (vulnerability management, open-source package validation), access control, documentation, data management (governance)
- **Risk-based validation**: focus testing effort on components that directly impact patient safety, data integrity, and product quality
- **SDLC phases**: requirements → design → coding → testing → validation → maintenance; each phase must be documented for full FDA traceability
- **Regulatory anchors**: 21 CFR Part 11 (electronic records), ICH E9 (statistical analyses), GAMP 5 (automated computerized systems)

## Methods / Concepts Covered

- [[GxP Validation]] — central concept; all 7 Good Practice domains defined
- Software Development Life Cycle (SDLC) — phased development with documented traceability

## Notable Quotes or Figures

> "Validation is a critical part of software development in clinical industries. It ensures that the software performs as expected and meets regulatory requirements."

## Connections

- Implements principles from: [[GxP Validation]]
- Related sources: [[Emily Yates — Validating GxP-Compliant R Shiny Apps]], [[GSWEP4R Workshop — R Package Engineering Workflow]]
- Regulatory context: [[Sponsor Responsibilities — IND Safety Reporting]]
- Related topic: [[R Package Validation in Regulated Environments]]

## Questions Raised

- How does GAMP 5 Category 5 (custom-developed software) apply specifically to R Shiny apps built by biostatisticians rather than software engineers?
- What is the minimum documented SDLC sufficient for a Phase 1 trial Shiny app versus a confirmatory Phase 3 submission tool?
